Financial
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Claroty
HQ United States · North America
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
At a glance
Financial health
Band: Not assessed
Customer rating
No reviews yet
Financial health
Band: Not assessedPrivately held
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
Products & services
Products not yet catalogued.
Risk summary
Full risk page with sources →Researched 8 Nov 2026
Adverse media
No adverse media (litigation, regulator action, restructuring or financial distress) involving Claroty found in HSH's search of the last 24 months.
Cyber & information governance
Oct 2025: A critical-rated authentication vulnerability (CVE-2025-54603) was published affecting Claroty Secure Access (SRA) versions 3.3.0 to 4.0.2; upgrading beyond 4.0.2 is advised. No confirmed exploitation found. NHS DSPT status not yet checked.
Regulatory & clinical safety
Cyber security software supplier; no regulatory or clinical safety actions found in the last 24 months.
Contract performance
No contract terminations, disputes or troubled implementations involving Claroty found in HSH's search of the last 24 months.
Competitors
No competitors linked yet.